Literature DB >> 33670502

Pentacyclic Triterpene Profile and Its Biosynthetic Pathway in Cecropia telenitida as a Prospective Dietary Supplement.

Gustavo Gutiérrez1, Laura Marcela Valencia1, Deisy Giraldo-Dávila2, Marianny Y Combariza2, Elkin Galeano3, Norman Balcazar4,5, Aram J Panay6, Alejandra Maria Jerez7, Guillermo Montoya1,8.   

Abstract

Promising research over the past decades has shown that some types of pentacyclic triterpenes (PTs) are associated with the prevention of type 2 diabetes (T2D), especially those found in foods. The most abundant edible sources of PTs are those belonging to the ursane and oleanane scaffold. The principal finding is that Cecropia telenitida contains abundant oleanane and ursane PT types with similar oxygenation patterns to those found in food matrices. We studied the compositional profile of a rich PT fraction (DE16-R) and carried out a viability test over different cell lines. The biosynthetic pathway connected to the isolated PTs in C. telenitida offers a specific medicinal benefit related to the modulation of T2D. This current study suggests that this plant can assemble isobaric, positional isomers or epimeric PT. Ursane or oleanane scaffolds with the same oxygenation pattern are always shared by the PTs in C. telenitida, as demonstrated by its biosynthetic pathway. Local communities have long used this plant in traditional medicine, and humans have consumed ursane and oleanane PTs in fruits since ancient times, two key points we believe useful in considering the medicinal benefits of C. telenitida and explaining how a group of molecules sharing a closely related scaffold can express effectiveness.

Entities:  

Keywords:  Cecropia telenitida; dietary supplement; pentacyclic triterpene; type 2 diabetes

Mesh:

Substances:

Year:  2021        PMID: 33670502      PMCID: PMC7922737          DOI: 10.3390/molecules26041064

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  35 in total

Review 1.  Environmental inhibitors of 11β-hydroxysteroid dehydrogenase type 2.

Authors:  Xue Ma; Qing-Quan Lian; Qiang Dong; Ren-Shan Ge
Journal:  Toxicology       Date:  2011-04-15       Impact factor: 4.221

Review 2.  Synergy research: approaching a new generation of phytopharmaceuticals.

Authors:  Hildebert Wagner
Journal:  Fitoterapia       Date:  2010-11-12       Impact factor: 2.882

3.  Isolation, characterisation and cytotoxicity study of arjunolic acid from Terminalia arjuna.

Authors:  A Sai Ramesh; J Godwin Christopher; R Radhika; C R Setty; V Thankamani
Journal:  Nat Prod Res       Date:  2011-07-07       Impact factor: 2.861

4.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.

Authors:  M B Hansen; S E Nielsen; K Berg
Journal:  J Immunol Methods       Date:  1989-05-12       Impact factor: 2.303

5.  Transcriptome sequencing and identification of cytochrome P450 monooxygenases involved in the biosynthesis of maslinic acid and corosolic acid in Avicennia marina.

Authors:  Mitsuki Nakamura; Tran My Linh; Le Quynh Lien; Hayato Suzuki; Nguyen Chi Mai; Vu Huong Giang; Keita Tamura; Nguyen Van Thanh; Hideyuki Suzuki; Ryo Misaki; Toshiya Muranaka; Ninh Khac Ban; Kazuhito Fujiyama; Hikaru Seki
Journal:  Plant Biotechnol (Tokyo)       Date:  2018-12-25       Impact factor: 1.133

6.  11beta-Hydroxysteroid dehydrogenase 1 inhibiting constituents from Eriobotrya japonica revealed by bioactivity-guided isolation and computational approaches.

Authors:  Judith M Rollinger; Denise V Kratschmar; Daniela Schuster; Petra H Pfisterer; Christel Gumy; Evelyne M Aubry; Sarah Brandstötter; Hermann Stuppner; Gerhard Wolber; Alex Odermatt
Journal:  Bioorg Med Chem       Date:  2010-01-11       Impact factor: 3.641

7.  Ginseng and ginsenoside Re do not improve β-cell function or insulin sensitivity in overweight and obese subjects with impaired glucose tolerance or diabetes.

Authors:  Dominic N Reeds; Bruce W Patterson; Adewole Okunade; John O Holloszy; Kenneth S Polonsky; Samuel Klein
Journal:  Diabetes Care       Date:  2011-03-16       Impact factor: 19.112

8.  What does it take to synergistically combine sub-potent natural products into drug-level potent combinations?

Authors:  Chu Qin; Kai Leng Tan; Cun Long Zhang; Chun Yan Tan; Yu Zong Chen; Yu Yang Jiang
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

9.  Pentacyclic Triterpenes from Cecropia telenitida Can Function as Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1.

Authors:  Catalina Mosquera; Aram J Panay; Guillermo Montoya
Journal:  Molecules       Date:  2018-06-14       Impact factor: 4.411

Review 10.  Licorice: From Pseudohyperaldosteronism to Therapeutic Uses.

Authors:  Chiara Sabbadin; Luciana Bordin; Gabriella Donà; Jacopo Manso; Giampiero Avruscio; Decio Armanini
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-18       Impact factor: 5.555

View more
  1 in total

Review 1.  State-of-the-Art and Opportunities for Bioactive Pentacyclic Triterpenes from Native Mexican Plants.

Authors:  Juan Antonio Alfaro-Almaguer; Luis Alberto Mejía-Manzano; José González-Valdez
Journal:  Plants (Basel)       Date:  2022-08-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.